Global Zika Virus Testing Market

1. Global Zika Virus Testing Market- Industry Analysis and Forecast (2020- 2026) By Test Type, End-Users and Region Global Zika Virus Testing Market was valued at $XX Mn in 2019 and is expected to account for market share of $XX Mn by 2026, at a CAGR of 7.2% during the forecast period. Global Zika Virus Testing Market Overview: Zika virus is a mosquito-borne virus transmitted by Aedes mosquitoes. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. Currently, there is no treatment or vaccine to protect specifically against Zika virus infection. In April 2017, CDC reported that 5,264 people were infected with Zika in the U.S., where more than 1,700 pregnant women were found Zika- positive and 58 babies were born with birth defects. Global Zika Virus Testing Market Dynamics: Demand for Point-of-care Diagnostics test results in rapid growth of market. According to the World Health Organization (WHO), about 84 countries are previously infected by ZIKV transmission. Thus, the rising prevalence of Zika virus infection primarily drives the market growth. Tests like RT-PCR, ELISA, which can be performed without any laboratory setup are considered POCT tests. Preference for ELISA test as point-of-care testing for Zika virus, due to its specificity and sensitivity. Initiatives are undertaken by the government for the development of innovative tests capable to detect the Zika virus, growing awareness about early detection of the

2. disease, and ongoing research and development activities fuel the market growth. Despite the technological advancements being introduced, the slow adoption of these technologies in some developing countries due to the high cost associated with them may impact negatively on the market growth. The report has profiled key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed. Global Zika Virus Testing Market Segment Analysis: The global Zika Virus Testing Market is segmented on the basis of Test Type and End-Users. Based on the Test type, the serological test segment is expected to show better growth during the forecast period. Serological tests are based on the detection of IgM and IgG antibodies in the patient’s serum with the help of ELISA-based tests. Increased preference for serological tests is due to its ability to detect acute as well as late- stage Zika virus infection in a shorter time span. They are also used for differential diagnosis of Zika virus against Flavivirus. The virus can be transmitted from an infected pregnant woman to a fetus and causes microcephaly and other severe brain anomalies. This has prompted the testing of pregnant women for the Zika virus, further fueling the growth of the market.

3. To Know About The Research Methodology :- Request Free Sample Report Global Zika Virus Testing Market Regional Insights: North America expected to continue dominant trend throughout forecast period.

4. Rising awareness about the early detection of infection and the advantages of the test kits are responsible for the market growth in the region. The government organizations, such as the Centers for Disease Control and Prevention (CDC), Pan American Health Organization (PAHO), etc., have been mainly involved in the prevention of Zika virus infection. As per the CDC, About 2 in 20 (10%) babies of women with confirmed Zika virus infection during pregnancy in US states, and about 1 in 20 (5%) in the US territories had Zika-associated birth defects. Besides this, technological advancements developed medical infrastructure, and increased healthcare expenditure also propels the market growth. Asia Pacific is anticipated to grow at a rapid pace during forecast period. Rising awareness among the population related to complications associated with the infection and ongoing research in the field of healthcare creates potential opportunities for market growth in the region. In India, the first four cases were reported in 2017; three in Gujarat and one in Tamil Nadu. In 2018, Zika Virus Outbreak was reported in the Rajasthan State. The report also helps in understanding Global Zika Virus Testing Market dynamics, structure by analyzing the market segments and projects the Global Zika Virus Testing Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Zika Virus Testing Market make the report investor’s guide. Scope of Global Zika Virus Testing Market report: Inquire before buying

5. Global Zika Virus Testing Market, By Region: • North America • Europe • South America • MEA • APAC Key Players operating in global Zika Virus Testing Market: • ELITechGroup • Siemens AG • Roche Molecular Systems Inc. • Abbott Laboratories • Fast Track Diagnostics Ltd. • Altona Diagnostics GmbH • MyBioSource.com • Primerdesign Ltd • Genekam • BIOCAN DIAGNOSTICS INC. Visit @: This Report Is Submitted By : Maximize Market Research Company

6. About Us: Maximize Market Research: Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.